In Three Places At Once…

Benjamin Ebert is the Nicola David-Pinedo Professor of Medicine at Harvard Medical School, Chair of Medical Oncology at the Dana-Farber Cancer Institute, and an Institute Member of the Broad Institute.

This is Benjamin Ebert

​Benjamin Ebert is the Nicola David-Pinedo Professor of Medicine at Harvard Medical School, Chair of Medical Oncology at the Dana-Farber Cancer Institute, and an Institute Member of the Broad Institute.

​Dr. Ebert received a bachelor’s degree from Williams College, a doctorate from Oxford University as a Rhodes Scholar, and an M.D. from Harvard Medical School. He completed a residency in internal medicine at Massachusetts General Hospital and a fellowship in hematology/oncology at the Dana-Farber Cancer Institute. He was on the faculty of Brigham and Women’s Hospital for 10 years before returning to the Dana-Farber.

“Along with human genetic studies, Dr. Ebert’s lab has made significant contributions to understanding the biological basis of transformation of hematopoietic cells by somatic mutations. His work has demonstrated creativity, innovative methodology, and direct human relevance.” – Sara Khalaf, American Society of Hematology

The Science

“At work, the best moments are talking through experiments with members in my lab; it’s exciting to hear about new data and ideas, and to dissect difficult problems. Those conversations are fun, enriching, challenging, and rewarding. Professionally, those high-level scientific discussions are a highlight of my day.”

  • We seek to determine the genetic mutations that drive myeloid malignancies, the clinical consequences of specific mutations, and the biological basis of malignant transformation. 
  • ​We ​systematically dissect  the the genetics of pre-malignant states in blood cancers and examine the effects of these pre-malignant states on the development of both cancer and non-malignant diseases.
  • We explore the development of novel therapeutics that modulate ubiquitin ligase activity to induce targeted protein degradation.

” I find it extremely exciting and rewarding to see trainees gain confidence as researchers, become independent investigators, and flourish scientifically and clinically. “